Bristol Myers Opdivo fails to meet primary endpoint in CheckMate -901 trial Ruchika Sharma19 May 2022 10:15 AM ISTUrothelial carcinoma, which most frequently begins in the cells that line the inside of the bladder, accounts for approximately 90% of bladder cancer...
Bristol Myers Squibb, Nektar halt Bempegaldesleukin, Opdivo cocktail trials for cancer treatment Ruchika Sharma16 April 2022 2:57 PM ISTPrinceton: Nektar Therapeutics and Bristol Myers Squibb have announced that based on results from pre-planned analyses of two...
Bristol Myers sues AstraZeneca over cancer-treatment patents MD Bureau19 March 2022 6:08 PM ISTBristol asked the Delaware court for an undisclosed amount of monetary damages.
USFDA accepts Bristol Myers Squibb's Application for Opdivo MD Bureau2 March 2022 12:10 PM ISTThe FDA granted the application Priority Review status and assigned a Prescription Drug User Fee Act (PDUFA) goal date of July 13, 2022.
Bristol-Myers, Eisai in up to USD 3.1 billion deal to develop cancer drug candidate Medical Dialogues Team19 Jun 2021 11:00 AM ISTNew Delhi: Bristol-Myers Squibb Co and Eisai Co said on Thursday they had entered into an agreement worth up to USD 3.10 billion to jointly develop...
FDA approves first immunotherapy for treatment of gastric cancer Dr. Kamal Kant Kohli17 April 2021 7:45 AM ISTThe U.S. Food and Drug Administration has approved first immunotherapy for the first-line treatment of gastric cancer. Opdivo (nivolumab), in...
FDA Approves Drug Combo for treatment of malignant pleural mesothelioma Hina Zahid2 Oct 2020 6:30 PM ISTThe U.S. Food and Drug Administration approved Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for the first-line treatment of adults with...
Bristol Myers anticipates recovery in sales of hospital-administered drugs, raises annual profit forecast Ruchika Sharma9 Aug 2020 9:15 AM ISTUS: Bristol Myers Squibb Co (BMY.N) on Thursday raised its annual profit forecast as it predicted a recovery in sales of its...
Bristol Myers gets USFDA nod to Opdivo, Yervoy combo for treating Lung Cancer Patients Farhat Nasim18 May 2020 5:18 PM ISTNew Delhi: Bristol Myers Squibb(BMS) recently announced that Opdivo (nivolumab) 3 mg/kg plus Yervoy (ipilimumab) 1 mg/kg (injections for...
Doctor falls victim to Online medicine Fraud Meghna A Singhania29 Jun 2017 4:21 PM ISTTelangana: A medical practitioner working in a private hospital in Telangana has lost Rs 4 lakh to online fraudsters after he tried to buy some cancer...
FDA declines expanded approval for Bristol-Myers' Opdivo drug Pooja Bhatia Bhatia28 Nov 2015 9:56 AM ISTBristol-Myers Squibb Co said the U.S. Food and Drug Administration declined to approve its immuno-oncology drug, Opdivo, for its expanded use to treat...
FDA approves Opdivo to treat advanced form of kidney cancer Pooja Bhatia Bhatia24 Nov 2015 10:10 AM ISTThe U.S. Food and Drug Administration today approved Opdivo (nivolumab) to treat patients with advanced (metastatic) renal cell carcinoma, a form of...
